References
- SerjeantGRSickle-cell diseaseLancet199735090797257309291916
- RobertsIde MontalembertMSickle cell disease as a paradigm of immigration hematology: new challenges for hematologists in EuropeHaematologica200792786587117606434
- BondsDRThree decades of innovation in the management of sickle cell disease: the road to understanding the sickle cell disease clinical phenotypeBlood Rev20051929911015603913
- OkpalaILeukocyte adhesion and the pathophysiology of sickle cell diseaseCurr Opin Hematol2006131404416319686
- NkrumahFKNeequayeJEAnkra-BaduGBone marrow in sickle cell anaemia at time of anaemic crisisArch Dis Child19845965615656742877
- SerjeantGRCeulaerCDLethbridgeRMorrisJSinghalAThomasPWThe painful crisis of homozygous sickle cell disease: clinical featuresBr J Haematol19948735865917993801
- BallasSKPain management of sickle cell diseaseHematol Oncol Clin North Am200519578580216214644
- ThomasVCognitive behavioural therapy in pain management for sickle cell diseaseInt J Palliat Nurs20006943444212388895
- BerzonRHaysRDShumakerSAInternational use, application and performance of health-related quality of life instrumentsQual Life Res1993263673688161974
- YawnBPJohn-SowahJManagement of sickle cell disease: recommendations from the 2014 expert panel reportAm Fam Physician201592121069107626760593
- BrandowAMPanepintoJAClinical interpretation of quantitative sensory testing as a measure of pain sensitivity in patients with sickle cell diseaseJ Pediatr Hematol Oncol201638428829326907660
- PopeMAlboCKidwellKMEvolution of chronic pain in sickle-cell diseaseBlood2016128221297
- TawficQAFarisASKausalyaRThe role of a low-dose ketamine-midazolam regimen in the management of severe painful crisis in patients with sickle cell diseaseJ Pain Symptom Manage201447233434023856095
- NeriCMPestieauSRDarbariDSLow-dose ketamine as a potential adjuvant therapy for painful vaso-occlusive crises in sickle cell diseasePaediatr Anaesth201323868468923565738
- AnieKAGreenJCochrane Cystic Fibrosis and Genetic Disorders GroupPsychological therapies for sickle cell disease and painCochrane Database Syst Rev2015327CD001916
- BallasSKGuptaKAdams-GravesPSickle cell pain: a critical reappraisalBlood2012120183647365622923496
- WatsonMLucasCHoyAWellsJOxford Handbook of Palliative Care2nd edOxford, UKOxford University Press2009
- RangHPPharmacology5th edEdinburghChurchill Livingstone2003234
- BallasSKPathophysiology and principles of management of the many faces of the acute vaso-occlusive crisis in patients with sickle cell diseaseEur J Haematol201595211312325288149
- JenningsCABobbBTNoreikaDMCoynePJOral ketamine for sickle cell crisis pain refractory to opioidsJ Pain Palliat Care Pharmacother201327215015423692261
- KueiNPatelNXuHCharacteristics and potential biomarkers for chronic pain in patients with sickle cell diseaseBlood201512623986
- Graido-GonzalezEDohertyJBergreenEPlasma endothelin-1, cytokine, and prostaglandin E2 levels in sickle cell disease and acute vaso-occlusive sickle crisisBlood198892725512555
- KhodorovaAMontmayeurJPStrichartzGEndothelin receptors and painJ Pain200910142819111868
- NeborDBowersAHardy-DessourcesMDFrequency of pain crises in sickle cell anemia and its relationship with the sympathovagal balance, blood viscosity and inflammationHaematologica201196111589159421750084
- SmithWRSchererMSickle-cell pain: advances in epidemiology and etiologyHematology Am Soc Hematol Educ Program20102010140941521239827
- JacobEChanVWHodgeCZeltzerLZurakowskiDSethnaNFSensory and thermal quantitative testing in children with sickle cell diseaseJ Pediatr Hematol Oncol201537318518925014619
- HollinsMStonerockGLKisaalitaNRJonesSOrringerEGilKMDetecting the emergence of chronic pain in sickle cell diseaseJ Pain Symptom Manage20124361082109322579409
- WangZJWilkieDJMolokieRNeurobiological mechanisms of pain in sickle cell diseaseHematology Am Soc Hematol Educ Program2010201040340821239826
- PortenoyRKTreatment of cancer painLancet201137797842236224721704873
- SchiavenatoMAlvarezOPain assessment during a vaso-occlusive crisis in the pediatric and adolescent patient: rethinking practiceJ Pediatr Oncol Nurs201330524224823850944
- HicksCLvon BaeyerCLSpaffordPAvan KorlaarIGoodenoughBThe Faces Pain Scale-Revised: toward a common metric in pediatric pain measurementPain200193217318311427329
- MerkelSVoepel-LewisTShayevitzJRMalviyaSThe FLACC: A behavioral scale for scoring postoperative pain in young childrenPediatr Nursing1997233293297
- World Health OrganizationCancer for Pain Relief with a Guide to Opioid AvailabilityGeneva, SwitzerlandWorld Health Organization1996
- PujolLAMontiDAManaging cancer pain with nonpharmacologic and complementary therapiesJ Am Osteopath Assoc200710712 Suppl 7ES15ES2118165373
- BallasSKManagement of sickle painCurr Opin Hematol1997421041119107526
- RichardREThe management of sickle cell painCurr Pain Headache Rep200913429529719586593
- OkomoUMeremikwuMMFluid replacement therapy for acute episodes of pain in people with sickle cell diseaseCochrane Database Syst Rev201266CD005406
- OsunkwoITangprichaVJames-HerryAProfound vitamin D deficiency in adolescents with sickle cell chronic painJ Investig Med2010582482
- QuinlanJCarterKAcute pain management in patients with persistent painCurr Opin Support Palliat Care20126218819322406985
- AnieKASteptoeAPain, mood and opioid medication use in sickle cell diseaseHematol J200341717312692524
- PayneRPain management in sickle cell anemiaAnesthesiol Clin North America1997152305318
- VijenthiraAStinsonJFriedmanJBenchmarking pain outcomes for children with sickle cell disease hospitalized in a tertiary referral pediatric hospitalPain Res Manag201217429129622891195
- YasterMKost-ByerlySMaxwellLGThe management of pain in sickle cell diseasePediatr Clin North Am200047369971010835998
- DampierCElyEBrodeckiDO’NealPO’NealPHome management of pain in sickle cell disease: a daily diary study in children and adolescentsJ Pediatr Hematol Oncol200224864364712439036
- SawyerJSickle cell pain management meets technology: Everybody winsAcute Pain20057113
- ContiCTsoEBrowneBOral morphine protocol for sickle cell crisis painMd Med J199645133358569458
- NiscolaPSorrentinoFScaramucciLde FabritiisPCianciulliPPain syndromes in sickle cell disease: an updatePain Med200910347048019416438
- TelferPCriddleJSandellJDaviesFMorrisonIChallandsJIntranasal diamorphine for acute sickle cell painArch Dis Child2009941297998019321506
- BrookoffDPolomanoRTreating sickle cell pain like cancer painAnn Intern Med199211653643681736768
- KrishnamurtiLSmith-PackardBGuptaACampbellMGunawardenaSSaladinoRImpact of individualized pain plan on the emergency management of children with sickle cell diseasePediatr Blood Cancer201461101747175324962217
- BuchananIDWoodwardMReedGWOpioid selection during sickle cell pain crisis and its impact on the development of acute chest syndromePediatr Blood Cancer200545571672415926170
- QariMHAljaouniSKAlardawiMSReduction of painful vaso-occlusive crisis of sickle cell anaemia by tinzaparin in a double-blind randomized trialThromb Haemost200798239239617721622
- SalehAWHillenHFDuitsAJLevels of endothelial, neutrophil and platelet-specific factors in sickle cell anemia patients during hydroxyurea therapyActa Haematol19991021313710473885
- BallasSKBausermanRLMcCarthyWFHydroxyurea and acute painful crises in sickle cell anemia: effects on hospital length of stay and opioid utilization during hospitalization, outpatient acute care contacts, and at homeJ Pain Symptom Manage201040687088220864308
- ColellaMPDe PaulaEVConranNHydroxyurea is associated with reductions in hypercoagulability markers in sickle cell anemiaJ Thromb Haemost20121091967197022817333
- GladwinMTShelhamerJHOgnibeneFPNitric oxide donor properties of hydroxyurea in patients with sickle cell diseaseBr J Haematol2002116243644411841449
- SparkenbaughEPawlinskiRInterplay between coagulation and vascular inflammation in sickle cell diseaseBr J Haematol2013162131423593937
- SmithWRBallasSKMcCarthyWFThe association between hydroxyurea treatment and pain intensity, analgesic use, and utilization in ambulatory sickle cell anemia patientsPain Med201112569770521481164
- YawnBPJohn-SowahJManagement of sickle cell disease: recommendations from the 2014 expert panel reportAm Fam Physician201592121069107626760593
- McGannPTWareREHydroxyurea for sickle cell anemia: what have we learned and what questions still remain?Curr Opin Hematol201118315816521372708
- CannasGPoutrelSThomasXHydroxycarbamine: from an old drug used in malignant hemopathies to a current standard in sickle cell diseaseMediterr J Hematol Infect Dis201791e201701528293403
- StallworthJRJerrellJMTripathiACost-effectiveness of hydroxyurea in reducing the frequency of pain episodes and hospitalization in pediatric sickle cell diseaseAm J Hematol2010851079579720645429
- SmithWRBallasSKMccarthyWFThe association between hydroxyurea treatment and pain intensity, analgesic use, and utilization in ambulatory sickle cell anemia patientsPain Med201112569770521481164
- InoueSKhanIMushtaqRPain management trend of vaso-occulsive crisis (VOC) at a community hospital emergency department (ED) for patients with sickle cell diseaseAnn Hematol201695222122526611852
- WoodKCGrangerDNSickle cell disease: role of reactive oxygen and nitrogen metabolitesClin Exp Pharmacol Physiol200734992693217645642
- GladwinMTKatoGJWeinerDNitric oxide for inhalation in the acute treatment of sickle cell pain crisis: a randomized controlled trialJAMA2011305989390221364138
- de FranceschiLMuraPSchweigerVFentanyl buccal tablet: a new breakthrough pain medication in early management of severe vaso-occlusive crisis in sickle cell diseasePain Pract201616668068726009799
- MallinsonTEA review of ketorolac as a prehospital analgesicJ Paramed Pract2017912522526
- BrousseauDCScottJPHilleryCAPanepintoJAThe effect of magnesium on length of stay for pediatric sickle cell pain crisisAcad Emerg Med200411996897215347549
- PowellCKolamunnage-DonaRLoweJMagnesium sulphate in acute severe asthma in children (MAGNETIC): a randomised, placebo-controlled trialLancet Respir Med20131430130824429155
- DudleyLHenderson-SmartDJWalkerGJChouDMagnesium sulphate versus diazepam for eclampsiaCochrane Database Syst Rev201012CD000127
- Melzer-LangeMDWalsh-KellyCMLeaGHilleryCAScottJPPatient-controlled analgesia for sickle cell pain crisis in a pediatric emergency departmentPediatr Emerg Care20042012414716157
- MyersMEckesEJA novel approach to pain management in persons with sickle cell diseaseMedsurg Nurs201221529329823243787
- ZubrzyckiMLieboldASkrabalCAssessment and pathophysiology of pain in cardiac surgeryJ Pain Res2018111599161130197534
- BallasSKViscusiEREpsteinKRManagement of acute chest wall sickle cell pain with nebulized morphineAm J Hematol200476219019115164390
- ShahNRollinsMLandiDShahRBaeJde CastroLMDifferences in pain management between hematologists and hospitalists caring for patients with sickle cell disease hospitalized for vasoocclusive crisisClin J Pain201430326626823669451
- WilsonBHNelsonJSickle cell disease pain management in adolescents: a literature reviewPain Manag Nurs201516214615125175555
- EnderKLKrajewskiJABabineauJUse of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell diseasePediatr Blood Cancer201461469369624249617
- JacobEThe pain experience of patients with sickle cell anemiaPain Manag Nurs200123748311710089
- EdwardsLYEdwardsCLPsychosocial treatments in pain management of sickle cell diseaseJ Natl Med Assoc2010102111084109421141299
- FieldTABeesonETJonesLKThe New ABCs: a practitioner’s guide to neuroscience-informed cognitive-behavior therapyJ Ment Health Couns2015373206220
- African Palliative Care AssociationBeating pain: a Pocket-guide for Pain Management in Africa’APCAKampala, Uganda2010 Available from: http://apps.who.int/medicinedocs/documents/s19114en/s19114en.pdfAccessed December 5, 2018